MicroTech Medical (Hangzhou) Co (HKSE:02235) Cash And Cash Equivalents : HK$2,061.8 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Cash And Cash Equivalents?

MicroTech Medical (Hangzhou) Co's quarterly cash and cash equivalents declined from Dec. 2022 (HK$2,285.44 Mil) to Jun. 2023 (HK$2,243.62 Mil) but then stayed the same from Jun. 2023 (HK$2,243.62 Mil) to Dec. 2023 (HK$2,061.80 Mil).

MicroTech Medical (Hangzhou) Co's annual cash and cash equivalents declined from Dec. 2021 (HK$2,633.80 Mil) to Dec. 2022 (HK$2,285.44 Mil) and declined from Dec. 2022 (HK$2,285.44 Mil) to Dec. 2023 (HK$2,061.80 Mil).

MicroTech Medical (Hangzhou) Co Cash And Cash Equivalents Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Cash And Cash Equivalents Chart

MicroTech Medical (Hangzhou) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

46.10

651.75

2,633.80

2,285.44

2,061.80

MicroTech Medical (Hangzhou) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial			2,633.80	2,466.00	2,285.44	2,243.62	2,061.80

MicroTech Medical (Hangzhou) Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

MicroTech Medical (Hangzhou) Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

Executives

Zheng Pan
Master Summer Limited	2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd	2201 Interest of corporation controlled by you
Cdbi Partners Fund Ii, L.p.	2201 Interest of corporation controlled by you
Cdbi Partners Fund I, L.p.	2201 Interest of corporation controlled by you
Cdbi Gp, Ltd	2201 Interest of corporation controlled by you
Cd Capital Healthcare Fund V, L.p.	2201 Interest of corporation controlled by you
Cd Capital Gp Ltd	2201 Interest of corporation controlled by you
Zhe Jiang Jiu Ren Zi Ben Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp V, L.p.	2201 Interest of corporation controlled by you
Qiming Venture Partners V, L.p.	2201 Interest of corporation controlled by you
Qm32 Limited	2101 Beneficial owner
Lav Asset Management (hong Kong) Limited	2102 Investment manager
Lav Evergreen (hong Kong) Co., Limited	2101 Beneficial owner

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines